What is the Prevalence of Low Health Literacy in European Union Member States? A Systematic Review and Meta-analysis.
Europe
health literacy
meta-analysis
prevalence
systematic review
Journal
Journal of general internal medicine
ISSN: 1525-1497
Titre abrégé: J Gen Intern Med
Pays: United States
ID NLM: 8605834
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
24
01
2020
accepted:
07
12
2020
pubmed:
7
1
2021
medline:
25
5
2021
entrez:
6
1
2021
Statut:
ppublish
Résumé
Many studies have shown that low health literacy (HL) is associated with several adverse outcomes. In this study, we systematically reviewed the prevalence of low HL in Europe. PubMed, Embase, and Scopus were searched. Cross-sectional studies conducted in the European Union (EU), published from 2000, investigating the prevalence of low HL in adults using a reliable tool, were included. Quality was assessed with the Newcastle-Ottawa Scale. Inverse-variance random effects methods were used to produce pooled prevalence estimates. A meta-regression analysis was performed to assess the association between low HL and the characteristics of the studies. The pooled prevalence of low HL ranged from of 27% (95% CI: 18-38%) to 48% (95% CI: 41-55%), depending on the literacy assessment method applied. Southern, Western, and Eastern EU countries had lower HL compared to northern Europe (β: 0.87, 95% CI: 0.40-1.35; β: 0.59, 95% CI: 0.25-0.93; and β: 0.72, 95% CI: 0.06-1.37, respectively). The assessment method significantly influenced the pooled estimate: compared to word recognition items, using self-reported comprehensions items (β: 0.61, 95% CI: 0.15-1.08), reading or numeracy comprehensions items (β: 0.77, 95% CI: 0.24-1.31), or a mixed method (β: 0.66, 95% CI: 0.01-1.33) found higher rates of low HL. Refugees had the lowest HL (β: 1.59, 95% CI: 0.26-2.92). Finally, lower quality studies reported higher rates of low HL (β: 0.56, 95% CI: 0.06-1.07). We found that low HL is a public health challenge throughout Europe, where one in every three to almost one in every two Europeans may not be able to understand essential health-related material. Additional research is needed to investigate the underlying causes and to develop remedies. CRD42019133377.
Sections du résumé
BACKGROUND
Many studies have shown that low health literacy (HL) is associated with several adverse outcomes. In this study, we systematically reviewed the prevalence of low HL in Europe.
METHODS
PubMed, Embase, and Scopus were searched. Cross-sectional studies conducted in the European Union (EU), published from 2000, investigating the prevalence of low HL in adults using a reliable tool, were included. Quality was assessed with the Newcastle-Ottawa Scale. Inverse-variance random effects methods were used to produce pooled prevalence estimates. A meta-regression analysis was performed to assess the association between low HL and the characteristics of the studies.
RESULTS
The pooled prevalence of low HL ranged from of 27% (95% CI: 18-38%) to 48% (95% CI: 41-55%), depending on the literacy assessment method applied. Southern, Western, and Eastern EU countries had lower HL compared to northern Europe (β: 0.87, 95% CI: 0.40-1.35; β: 0.59, 95% CI: 0.25-0.93; and β: 0.72, 95% CI: 0.06-1.37, respectively). The assessment method significantly influenced the pooled estimate: compared to word recognition items, using self-reported comprehensions items (β: 0.61, 95% CI: 0.15-1.08), reading or numeracy comprehensions items (β: 0.77, 95% CI: 0.24-1.31), or a mixed method (β: 0.66, 95% CI: 0.01-1.33) found higher rates of low HL. Refugees had the lowest HL (β: 1.59, 95% CI: 0.26-2.92). Finally, lower quality studies reported higher rates of low HL (β: 0.56, 95% CI: 0.06-1.07).
DISCUSSION
We found that low HL is a public health challenge throughout Europe, where one in every three to almost one in every two Europeans may not be able to understand essential health-related material. Additional research is needed to investigate the underlying causes and to develop remedies.
PROSPERO REGISTRATION
CRD42019133377.
Identifiants
pubmed: 33403622
doi: 10.1007/s11606-020-06407-8
pii: 10.1007/s11606-020-06407-8
pmc: PMC7947142
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
753-761Références
Eur J Vasc Endovasc Surg. 2018 Aug;56(2):239-245
pubmed: 29891435
BMC Health Serv Res. 2019 Jul 23;19(1):513
pubmed: 31337406
Br Med Bull. 2017 Jan 1;121(1):5-18
pubmed: 28108435
Prev Med. 2014 Apr;61:100-5
pubmed: 24287122
Aging Clin Exp Res. 2019 Apr;31(4):549-556
pubmed: 30578457
J Public Health (Oxf). 2008 Dec;30(4):449-55
pubmed: 18660507
Blood Press. 2018 Aug;27(4):194-199
pubmed: 29366359
PLoS One. 2018 Dec 6;13(12):e0208303
pubmed: 30521588
Neth Heart J. 2017 Jul;25(7-8):446-454
pubmed: 28247247
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
JAMA Surg. 2018 Aug 1;153(8):738-745
pubmed: 29710226
BMC Public Health. 2014 Oct 03;14:1030
pubmed: 25278109
Scand J Caring Sci. 2015 Sep;29(3):573-81
pubmed: 25622511
Int J Public Health. 2018 Apr;63(3):409-419
pubmed: 29480325
Aten Primaria. 2017 Jan;49(1):28-34
pubmed: 27236716
Evid Rep Technol Assess (Full Rep). 2012 Aug;(208.3):1-475
pubmed: 24422952
Rev Saude Publica. 2012 Oct;46(5):918-22
pubmed: 23128269
BMJ Open. 2018 Jul 6;8(7):e022132
pubmed: 29982220
Front Public Health. 2017 Dec 11;5:335
pubmed: 29312916
Kidney Int. 2016 Sep;90(3):685-95
pubmed: 27521115
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Ann Ig. 2017 May-Jun;29(3):171-178
pubmed: 28383608
Patient Educ Couns. 2014 Jun;95(3):421-8
pubmed: 24698535
Leuk Res. 2018 Oct;73:44-50
pubmed: 30216938
J Epidemiol Community Health. 2007 Dec;61(12):1086-90
pubmed: 18000132
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Sep;58(9):942-50
pubmed: 26227894
Semergen. 2019 Jan - Feb;45(1):30-36
pubmed: 30309699
PLoS One. 2018 Feb 23;13(2):e0193336
pubmed: 29474470
Prog Transplant. 2018 Dec;28(4):338-342
pubmed: 30205755
J Health Commun. 2014;19 Suppl 2:106-14
pubmed: 25315587
Respir Med. 2016 Jun;115:78-82
pubmed: 27215508
Perspect Public Health. 2012 Jan;132(1):39-42
pubmed: 22458151
Ann Intern Med. 2011 Jul 19;155(2):97-107
pubmed: 21768583
BMC Public Health. 2015 Sep 10;15:883
pubmed: 26357978
PLoS One. 2018 Dec 6;13(12):e0208091
pubmed: 30521552
Health Expect. 2017 Feb;20(1):112-119
pubmed: 26774107
Evid Rep Technol Assess (Full Rep). 2011 Mar;(199):1-941
pubmed: 23126607
Prev Med Rep. 2019 Apr 25;14:100876
pubmed: 31080706
J Health Commun. 2011;16 Suppl 3:134-49
pubmed: 21951248
Clin Oncol (R Coll Radiol). 2011 Apr;23(3):223-7
pubmed: 21186100
Prim Health Care Res Dev. 2018 Feb 15;:1-18
pubmed: 29444735
BMJ Open. 2013 Jan 03;3(1):
pubmed: 23293243
Am J Health Syst Pharm. 2004 Oct 1;61(19):2043-9
pubmed: 15509127
Public Health. 2019 Feb;167:8-15
pubmed: 30544041
BMJ Open. 2019 Jun 19;9(6):e026356
pubmed: 31221877
Eur J Public Health. 2015 Dec;25(6):1053-8
pubmed: 25843827
EGEMS (Wash DC). 2017 Dec 15;5(3):7
pubmed: 29930971
Ann Ist Super Sanita. 2018 Jul-Sep;54(3):214-222
pubmed: 30284548
PLoS One. 2018 Feb 15;13(2):e0193079
pubmed: 29447274
Acta Med Port. 2017 Dec 29;30(12):861-869
pubmed: 29364799
Scott Med J. 2007 May;52(2):21-4
pubmed: 17536637
J Health Commun. 2012;17 Suppl 3:100-8
pubmed: 23030564
Pharm Pract (Granada). 2012 Jul;10(3):143-50
pubmed: 24155830
Arch Public Health. 2019 Apr 2;77:17
pubmed: 30984392
Biomed Res Int. 2017;2017:8516843
pubmed: 29130048
J Epidemiol Community Health. 2016 Oct;70(10):1032-8
pubmed: 27116951
Oncologist. 2017 Oct;22(10):1197-1211
pubmed: 28606972
Am J Med. 2005 Apr;118(4):371-7
pubmed: 15808134
Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):716-21
pubmed: 26016832
Ann Intern Med. 2019 Nov 5;171(9):677-679
pubmed: 31357212
Health Policy. 2016 Sep;120(9):1087-94
pubmed: 27593949
Int J Med Inform. 2016 Jul;91:60-6
pubmed: 27185509
Res Synth Methods. 2010 Jan;1(1):39-65
pubmed: 26056092
Health Expect. 2017 Oct;20(5):1049-1060
pubmed: 28402013
BMC Health Serv Res. 2017 Jun 19;17(1):410
pubmed: 28629412
BMC Public Health. 2016 Nov 9;16(1):1151
pubmed: 27829401
Prim Care Diabetes. 2018 Aug;12(4):331-337
pubmed: 29559207
JMIR Res Protoc. 2017 Nov 13;6(11):e221
pubmed: 29133284
Musculoskeletal Care. 2019 Jun;17(2):174-182
pubmed: 30762926
J Gen Intern Med. 2005 Feb;20(2):175-84
pubmed: 15836552
Patient Educ Couns. 2014 Nov;97(2):269-75
pubmed: 25107513
Am J Public Health. 2002 Aug;92(8):1278-83
pubmed: 12144984
Stat Med. 1999 Oct 30;18(20):2693-708
pubmed: 10521860
Patient Educ Couns. 2018 Mar;101(3):511-517
pubmed: 28899712
J Gen Intern Med. 2006 Aug;21(8):884-7
pubmed: 16881952
J Gerontol B Psychol Sci Soc Sci. 2016 May;71(3):445-57
pubmed: 25504637
J Health Commun. 2013;18 Suppl 1:172-84
pubmed: 24093354
Res Synth Methods. 2019 Mar;10(1):83-98
pubmed: 30067315
Dtsch Arztebl Int. 2017 Jan 27;114(4):53-60
pubmed: 28211318
BMC Public Health. 2012 Jan 25;12:80
pubmed: 22276600
Ann Ist Super Sanita. 2017 Jul-Sep;53(3):205-212
pubmed: 28956799
Am J Prev Med. 2016 Oct;51(4):463-72
pubmed: 27140501
Psychooncology. 2015 Apr;24(4):478-86
pubmed: 25241852
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120